• Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021
  • The company filed its condensed interim consolidated financial statements
  • The company generated revenues of $17.0 million for the quarter
  • The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth
  • Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET

Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021.

The Canadian healthtech company filed its condensed interim consolidated financial statements.

The company generated revenues of $17.0 million for the quarter ($30.4 million for the 6-month period compared to $8.2 million for the same period in 2020).

The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth.

“The March offering and the latest technology roll out puts us in a very enviable position to act as an aggregator in our market,” said Premier Health CEO Martin Legault.

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals.

Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET.

More From The Market Online

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.